Metraipolis › archive › dc_026ebc4e91f7

Plasma immune proteome-based risk score predicts survival in advanced gastric cancer treated with PD-1 inhibitors and chemotherapy — Europe PMC PMID:41601673

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41601673
DOI: 10.3389/fimmu.2025.1715993
License (as archived): solo-consultazione
Archived: 2026-11-06T21:21:30.168Z
SHA-256 of the archived text: 1bb1ce4a1f9d9dc26911d086aa12bae93dd1139dc619cb5497606d92588e2611
Stable URL of this page: https://metraipolis.com/documento/dc_026ebc4e91f7

How to cite

Plasma immune proteome-based risk score predicts survival in advanced gastric cancer treated with PD-1 inhibitors and chemotherapy — Europe PMC PMID:41601673 — Europe PMC (en), https://europepmc.org/article/MED/41601673 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_026ebc4e91f7 (Metraipolis archive dc_026ebc4e91f7, sha256 1bb1ce4a1f9d9dc26911d086aa12bae93dd1139dc619cb5497606d92588e2611)

BibTeX

@misc{dc026ebc4e91f7,
  title = {Plasma immune proteome-based risk score predicts survival in advanced gastric cancer treated with PD-1 inhibitors and chemotherapy — Europe PMC PMID:41601673},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41601673},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_026ebc4e91f7; sha256 1bb1ce4a1f9d9dc26911d086aa12bae93dd1139dc619cb5497606d92588e2611},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41601673. Agents can read the archived copy with the MCP tool read_document.